Cargando…
Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
Treatment of head and neck cancers requires multidisciplinary collaboration to reduce morbidity and mortality associated with the tumor burden, as well as to preserve function of organs and structures. With the use of various new targeted therapies come new adverse events including dermatologic toxi...
Autores principales: | Espinosa, Maria L., Abad, Chelsea, Kurtzman, Yaira, Abdulla, Farah R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190330/ https://www.ncbi.nlm.nih.gov/pubmed/34123780 http://dx.doi.org/10.3389/fonc.2021.605941 |
Ejemplares similares
-
Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021) -
Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019) -
Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
por: Qian, Jack M., et al.
Publicado: (2021) -
Bibliometric study on the knowledge graph of immunotherapy for head and neck cancer
por: Wang, Ji, et al.
Publicado: (2023) -
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
por: Shibata, Hirofumi, et al.
Publicado: (2021)